What medications should be given to a patient with benign paroxysmal positional vertigo who has significant nausea or vomiting that interferes with the repositioning maneuver, and what are the recommendations if the condition is later identified as vestibular neuritis?

Medication Management for BPPV with Severe Nausea/Vomiting and Vestibular Neuritis

For BPPV patients with nausea or vomiting that interferes with repositioning maneuvers, use vestibular suppressants (antihistamines, anticholinergics, or benzodiazepines) for immediate symptom relief only—just enough to allow the repositioning maneuver to be performed—then discontinue them immediately afterward. 1

BPPV with Severe Nausea/Vomiting

The 2017 AAO-HNS guideline is explicit that medications in BPPV serve only one purpose: relief of immediate distress such as nausea 1. The guideline emphasizes that medications do not treat the underlying BPPV process itself 1.

Specific Medication Approach:

• Use vestibular suppressants temporarily to control nausea/vomiting enough to perform the Epley or Semont maneuver
• Options include:
  • Antihistamines (e.g., meclizine)
  • Anticholinergics
  • Benzodiazepines 2
  • Dopamine antagonists for severe nausea 2

Critical Caveat:

Stop vestibular suppressants immediately after the repositioning maneuver is completed. These medications can impair vestibular compensation and delay recovery 2, 3. The guideline specifically discourages routine use of vestibular suppressants beyond immediate symptom control 1.

Treatment Algorithm:

1. Attempt repositioning maneuver first without medication
2. If nausea/vomiting prevents completion → give single dose of vestibular suppressant
3. Wait 30-60 minutes for symptom control
4. Perform repositioning maneuver (Epley for posterior canal, Gufoni for horizontal canal) 4
5. Discontinue all vestibular suppressants
6. Do NOT prescribe ongoing vestibular suppressants for home use 3

If Later Diagnosed as Vestibular Neuritis

If the diagnosis changes to vestibular neuritis, use vestibular suppressants only for the first 2-3 days of acute symptoms, then stop them to allow vestibular compensation to occur. 2

Key Differences from BPPV:

• Vestibular neuritis requires brief (not single-dose) vestibular suppressant use during the acute phase 2
• Anticholinergics and benzodiazepines are the mainstays 2
• After 2-3 days, discontinue all suppressants to promote central compensation 2
• Consider early vestibular rehabilitation therapy once acute symptoms subside 2

Common Pitfall:

The most common error is prescribing ongoing vestibular suppressants (like meclizine) for days or weeks in either condition 3. This delays recovery and impairs the brain's natural compensation mechanisms 2. Current evidence shows that brain imaging and prolonged medication use are not recommended for BPPV management 3.